Humanwell Healthcare Group Co Ltd (600079) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.048x

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has a cash flow conversion efficiency ratio of 0.048x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥903.00 Million ≈ $132.14 Million USD) by net assets (CN¥18.96 Billion ≈ $2.77 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Humanwell Healthcare Group Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Humanwell Healthcare Group Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Humanwell Healthcare Group Co Ltd (600079) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Humanwell Healthcare Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HLA GROUP CORP LTD
SHG:600398
0.126x
Whitehaven Coal Ltd
AU:WHC
0.050x
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
-0.047x
Methanex Corporation
TO:MX
0.034x
Magnolia Oil & Gas Corp
NYSE:MGY
0.123x
BICECORP S.A
SN:BICECORP
0.214x
Etablissementen Franz Colruyt NV
BR:COLR
0.070x
Jiangsu Aucksun Co Ltd
SHE:002245
0.036x

Annual Cash Flow Conversion Efficiency for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Humanwell Healthcare Group Co Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see 600079 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥20.69 Billion
≈ $3.03 Billion
CN¥2.16 Billion
≈ $316.70 Million
0.105x +6.85%
2023-12-31 CN¥20.10 Billion
≈ $2.94 Billion
CN¥1.97 Billion
≈ $287.87 Million
0.098x -28.06%
2022-12-31 CN¥17.94 Billion
≈ $2.63 Billion
CN¥2.44 Billion
≈ $357.21 Million
0.136x -2.28%
2021-12-31 CN¥15.65 Billion
≈ $2.29 Billion
CN¥2.18 Billion
≈ $318.83 Million
0.139x -13.81%
2020-12-31 CN¥12.94 Billion
≈ $1.89 Billion
CN¥2.09 Billion
≈ $305.80 Million
0.162x +10.95%
2019-12-31 CN¥14.00 Billion
≈ $2.05 Billion
CN¥2.04 Billion
≈ $298.20 Million
0.146x +244.59%
2018-12-31 CN¥14.27 Billion
≈ $2.09 Billion
CN¥602.99 Million
≈ $88.24 Million
0.042x +651.64%
2017-12-31 CN¥16.61 Billion
≈ $2.43 Billion
CN¥93.35 Million
≈ $13.66 Million
0.006x -87.21%
2016-12-31 CN¥11.98 Billion
≈ $1.75 Billion
CN¥526.48 Million
≈ $77.04 Million
0.044x +29.63%
2015-12-31 CN¥9.18 Billion
≈ $1.34 Billion
CN¥311.22 Million
≈ $45.54 Million
0.034x -61.38%
2014-12-31 CN¥5.73 Billion
≈ $838.16 Million
CN¥502.70 Million
≈ $73.56 Million
0.088x -10.50%
2013-12-31 CN¥5.08 Billion
≈ $743.41 Million
CN¥498.22 Million
≈ $72.90 Million
0.098x +107.76%
2012-12-31 CN¥3.65 Billion
≈ $534.05 Million
CN¥172.27 Million
≈ $25.21 Million
0.047x +57.24%
2011-12-31 CN¥3.14 Billion
≈ $459.33 Million
CN¥94.23 Million
≈ $13.79 Million
0.030x -37.27%
2010-12-31 CN¥2.33 Billion
≈ $340.61 Million
CN¥111.39 Million
≈ $16.30 Million
0.048x -35.55%
2009-12-31 CN¥2.08 Billion
≈ $304.49 Million
CN¥154.51 Million
≈ $22.61 Million
0.074x +163.33%
2008-12-31 CN¥1.24 Billion
≈ $181.47 Million
CN¥34.97 Million
≈ $5.12 Million
0.028x -40.22%
2007-12-31 CN¥1.17 Billion
≈ $170.79 Million
CN¥55.05 Million
≈ $8.06 Million
0.047x -38.05%
2006-12-31 CN¥1.11 Billion
≈ $162.28 Million
CN¥84.44 Million
≈ $12.36 Million
0.076x -53.95%
2005-12-31 CN¥768.89 Million
≈ $112.51 Million
CN¥127.13 Million
≈ $18.60 Million
0.165x +69.80%
2004-12-31 CN¥724.52 Million
≈ $106.02 Million
CN¥70.55 Million
≈ $10.32 Million
0.097x +37.38%
2003-12-31 CN¥681.54 Million
≈ $99.73 Million
CN¥48.31 Million
≈ $7.07 Million
0.071x +66.56%
2001-12-31 CN¥396.54 Million
≈ $58.03 Million
CN¥16.88 Million
≈ $2.47 Million
0.043x -47.20%
2000-12-31 CN¥325.09 Million
≈ $47.57 Million
CN¥26.20 Million
≈ $3.83 Million
0.081x --

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.25 Billion
CN¥29.07 Billion CNY
Market Cap Rank
#3962 Global
#583 in China
Share Price
CN¥17.81
Change (1 day)
+0.74%
52-Week Range
CN¥16.37 - CN¥23.03
All Time High
CN¥37.30
About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more